3-fluoro-5,7-dihydroxy-4-methyl-2H-chromen-2-one | 105440-96-8

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 香豆素及其衍生物
• 英文名称: 3-fluoro-5,7-dihydroxy-4-methyl-2H-chromen-2-one
• 英文别名: 3-Fluoro-5,7-dihydroxy-4-methylchromen-2-one
• CAS: 105440-96-8
• 化学式: C₁₀H₇FO₄
• 分子量: 210.162
• InChiKey: WEHBKAXTXCIUKK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  15
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3-fluoro-5,7-dihydroxy-4-methyl-2H-chromen-2-one 在 N-溴代丁二酰亚胺(NBS) 作用下， 以 二氯甲烷 为溶剂， 生成 8-bromo-3-fluoro-5,7-dihydroxy-4-methyl-2H-chromen-2-one
  参考文献：
  名称：

  Derivatives of Natural Product Agrimophol as Disruptors of Intrabacterial pH Homeostasis in Mycobacterium tuberculosis

  摘要：

  This article reports the rational medicinal chemistry of a natural product, agrimophol (1), as a new disruptor of intrabacterial pH (pH(IB)) homeostasis in Mycobacterium tuberculosis (Mtb). Through the systematic investigation of the structure-activity relationship of 1, scaffold-hopping of the diphenylmethane scaffold, pharmacophore displacement strategies, and studies of the structure-metabolism relationship, a new derivative 5a was achieved. Compound 5a showed 100-fold increased potency in the ability to reduce pH(IB) to pH 6.0 and similarly improved mycobactericidal activity compared with 1 against both Mycobacterium bovis-BCG and Mtb. Compound 5a possessed improved metabolic stability in human liver microsomes and hepatocytes, lower cytotoxicity, higher selectivity index, and similar pK(a) value to natural 1. This study introduces a novel scaffold to an old drug, resulting in improved mycobactericidal activity through decreasing pH(IB), and may contribute to the critical search for new agents to overcome drug resistance and persistence in the treatment of tuberculosis.

  DOI：

  10.1021/acsinfecdis.8b00325
• 作为产物：
  描述：

  间苯三酚 、 2-氟乙酰乙酸乙酯 在 三氟化硼乙醚 作用下， 以 乙醇 为溶剂， 以84%的产率得到3-fluoro-5,7-dihydroxy-4-methyl-2H-chromen-2-one
  参考文献：
  名称：

  具有抑制结核分枝杆菌活性的新型二苯甲基 类化合物

  摘要：

  本发明涉及具有抑制结核分枝杆菌活性的新型二苯甲基类衍生物及其制备方法，特别是具有抑制复制性和非复制性结核分枝杆菌活性的新型二苯甲基类衍生物及其制备方法。具体地，本发明涉及式(I)所示的化合物或其所有可能的异构体、前药、可药用盐、溶剂合物或水合物，其中各变量如说明书所述。还涉及本发明化合物的制备方法、包含本发明化合物的药物组合物、以及本发明化合物在制备抗结核分枝杆菌感染引起的疾病的药物中的用途。

  公开号：

  CN109293493B

文献信息

• Synthetic Calanolides with Bactericidal Activity against Replicating and Nonreplicating <i>Mycobacterium tuberculosis</i>
  作者：Purong Zheng、Selin Somersan-Karakaya、Shichao Lu、Julia Roberts、Maneesh Pingle、Thulasi Warrier、David Little、Xiaoyong Guo、Steven J. Brickner、Carl F. Nathan、Ben Gold、Gang Liu

  DOI：10.1021/jm4019228

  日期：2014.5.8

  It is urgent to introduce new drugs for tuberculosis to shorten the prolonged course of treatment and control drug-resistant Mycobacterium tuberculosis (Mtb). One strategy toward this goal is to develop antibiotics that eradicate both replicating (R) and nonreplicating (NR) Mtb. Naturally occurring (+)-calanolide A was active against R-Mtb. The present report details the design, synthesis, antimycobacterial activities, and structure-activity relationships of synthetic calanolides. We identified potent dual-active nitro-containing calanolides with minimal in vitro toxicity that were cidal to axenic Mtb and Mtb in human macrophages, while sparing Gram-positive and -negative bacteria and yeast. Two of the nitrobenzofuran-containing lead compounds were found to be genotoxic to mammalian cells. Although genotoxicity precluded clinical progression, the profound, selective mycobactericidal activity of these calanolides will be useful in identifying pathways for killing both R- and NR-Mtb, as well as in further structure-based design of more effective and drug-like antimycobacterial agents.
• TAKAOKA, AKIO;IBRAHIM, M. KAMAL;KAGARUKI, S. R. F.;ISHIKAWA, NOBUO, J. CHEM. SOC. JAP., CHEM. AND IND. CHEM., 1985, N 11, 2169-2176
  作者：TAKAOKA, AKIO、IBRAHIM, M. KAMAL、KAGARUKI, S. R. F.、ISHIKAWA, NOBUO

  DOI：——

  日期：——
• 具有抑制结核分枝杆菌活性的新型二苯甲基 类化合物
  申请人：清华大学

  公开号：CN109293493B

  公开（公告）日：2021-08-03

  本发明涉及具有抑制结核分枝杆菌活性的新型二苯甲基类衍生物及其制备方法，特别是具有抑制复制性和非复制性结核分枝杆菌活性的新型二苯甲基类衍生物及其制备方法。具体地，本发明涉及式(I)所示的化合物或其所有可能的异构体、前药、可药用盐、溶剂合物或水合物，其中各变量如说明书所述。还涉及本发明化合物的制备方法、包含本发明化合物的药物组合物、以及本发明化合物在制备抗结核分枝杆菌感染引起的疾病的药物中的用途。
• Derivatives of Natural Product Agrimophol as Disruptors of Intrabacterial pH Homeostasis in <i>Mycobacterium tuberculosis</i>
  作者：Jie Wu、Ran Mu、Mingna Sun、Nan Zhao、Miaomiao Pan、Hongshuang Li、Yi Dong、Zhaogang Sun、Jie Bai、Minwan Hu、Carl F. Nathan、Babak Javid、Gang Liu

  DOI：10.1021/acsinfecdis.8b00325

  日期：2019.7.12

  This article reports the rational medicinal chemistry of a natural product, agrimophol (1), as a new disruptor of intrabacterial pH (pH(IB)) homeostasis in Mycobacterium tuberculosis (Mtb). Through the systematic investigation of the structure-activity relationship of 1, scaffold-hopping of the diphenylmethane scaffold, pharmacophore displacement strategies, and studies of the structure-metabolism relationship, a new derivative 5a was achieved. Compound 5a showed 100-fold increased potency in the ability to reduce pH(IB) to pH 6.0 and similarly improved mycobactericidal activity compared with 1 against both Mycobacterium bovis-BCG and Mtb. Compound 5a possessed improved metabolic stability in human liver microsomes and hepatocytes, lower cytotoxicity, higher selectivity index, and similar pK(a) value to natural 1. This study introduces a novel scaffold to an old drug, resulting in improved mycobactericidal activity through decreasing pH(IB), and may contribute to the critical search for new agents to overcome drug resistance and persistence in the treatment of tuberculosis.